<DOC>
	<DOC>NCT02890875</DOC>
	<brief_summary>Patients on long-term parenteral nutrition (PN) are at high risk for central line-associated bloodstream infections (CLABSI). This study evaluates the efficacy and safety of ethanol lock therapy for CLABSI prophylaxis in adult patients on PN.</brief_summary>
	<brief_title>Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Catheter-Related Infections</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Adult patients (ages 1880) on PN with siliconebased central venous catheters Weight â‰¤ 50 kg Allergy/hypersensitivity/intolerance to ethanol or heparin Pregnancy or breastfeeding Patient taking metronidazole, disulfiram, or isoniazid History of alcohol abuse History of heparininduced thrombocytopenia (HIT) or have an active hypocoagulable state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>ethanol lock</keyword>
	<keyword>parenteral nutrition</keyword>
</DOC>